Live Breaking News & Updates on Biocare Lifescience Inc
Stay updated with breaking news from Biocare lifescience inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA officer-in-charge Oscar Gutierrez said the drug regulator has approved the application of the Department of Health for a special permit for the institutional use of Bexovid, the first generic version of Pfizer’s Paxlovid. ....
FDA OK's generic version of Pfizer's pill vs coronavirus bworldonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bworldonline.com Daily Mail and Mail on Sunday newspapers.
MANILA - The Food and Drug Administration (FDA) has granted a compassionate special permit (CSP) for the Covid-19 treatment drug Bexovid, the first generic version of Pfizer's Paxlovid. Bexovid may be used for individuals with mild to moderate symptoms of Covid-19 ages 12 years old and above. It can reduce risks of hospitalization and deaths by 88 to 89 percent when taken within three to five days from the onset of symptoms. "So, dahil ito po ay generic, ito po ay inaasahan na mas mura po ang cost of treatment compared to Paxlovid, at ito po ay ibinigay itong CSP sa DOH(because this is generic, its cost of treatment is expected to be cheaper compared to Paxlovid, and the CSP was given to DOH)," FDA officer-in -charge Dr. Oscar Gutierrez said in his report to President Rodrigo Duterte Monday. He added that the DOH can make the drug accessible and available to government hospitals once Biocare Lifescience Inc., a Philippine based pharmaceutical distributor, processes the de ....
Medicines (File photo / MANILA BULLETIN) The Food and Drug Administration (FDA) has granted a compassionate special permit (CSP) for coronavirus disease (COVID-19) drug Bexovid, which is the generic version of Pfizer’s COVID-19 pill Paxlovid. “Mr. President, na-approve po ng FDA ang application ng ....